Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Centessa Pharmaceuticals Announced Interim Data From An Ongoing Phase 1 Trial Of ORX750, In Acutely Sleep-deprived Healthy Volunteers, Showing Clinically Meaningful And Statistically Significant Improvements In Mean Sleep Latency At The First Two Doses Evaluated Vs. Placebo

Author: Benzinga Newsdesk | September 10, 2024 07:06am

Posted In: CNTA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist